MetLife Investment Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.24M Sell
29,114
-1,239
-4% -$246K 0.03% 601
2025
Q4
$6.59M Sell
30,353
-1,380
-4% -$302K 0.03% 502
2025
Q3
$8.14M Sell
31,733
-884
-3% -$222K 0.04% 430
2025
Q2
$8.46M Sell
32,617
-643
-2% -$164K 0.05% 372
2025
Q1
$8.1M Sell
33,260
-615
-2% -$155K 0.04% 409
2024
Q4
$8.63M Buy
33,875
+592
+2% +$159K 0.05% 307
2024
Q3
$9.78M Sell
33,283
-818
-2% -$231K 0.06% 263
2024
Q2
$8.27M Buy
34,101
+1,775
+5% +$423K 0.05% 287
2024
Q1
$8.65M Sell
32,326
-1,032
-3% -$263K 0.06% 269
2023
Q4
$8.25M Sell
33,358
-490
-1% -$99.4K 0.06% 261
2023
Q3
$6.2M Sell
33,848
-777
-2% -$159K 0.05% 326
2023
Q2
$8.15M Buy
34,625
+608
+2% +$128K 0.06% 262
2023
Q1
$6.9M Sell
34,017
-359
-1% -$74.7K 0.05% 309
2022
Q4
$6.68M Sell
34,376
-615
-2% -$112K 0.05% 313
2022
Q3
$6M Sell
34,991
-436
-1% -$85.4K 0.05% 328
2022
Q2
$6.48M Buy
35,427
+178
+0.5% +$35.6K 0.05% 309
2022
Q1
$8.36M Buy
35,249
+8,294
+31% +$1.95M 0.05% 298
2021
Q4
$7.89M Sell
26,955
-563
-2% -$157K 0.06% 247
2021
Q3
$6.97M Sell
27,518
-698
-2% -$181K 0.06% 257
2021
Q2
$6.76M Sell
28,216
-809
-3% -$181K 0.06% 271
2021
Q1
$5.26M Sell
29,025
-517
-2% -$91.3K 0.05% 365
2020
Q4
$5.7M Sell
29,542
-1,252
-4% -$210K 0.05% 317
2020
Q3
$4.83M Sell
30,794
-952
-3% -$156K 0.05% 329
2020
Q2
$5.46M Buy
31,746
+535
+2% +$79.3K 0.06% 281
2020
Q1
$3.73M Sell
31,211
-955
-3% -$139K 0.05% 347
2019
Q4
$4.51M Sell
32,166
-731
-2% -$101K 0.05% 406
2019
Q3
$4.63M Sell
32,897
-407
-1% -$57.4K 0.05% 370
2019
Q2
$4.5M Sell
33,304
-1,004
-3% -$126K 0.05% 398
2019
Q1
$4.07M Sell
34,308
-172
-0.5% -$18.4K 0.04% 442
2018
Q4
$3.21M Sell
34,480
-547
-2% -$58.2K 0.04% 510
2018
Q3
$4.57M Sell
35,027
-382
-1% -$49.8K 0.05% 401
2018
Q2
$4.43M Sell
35,409
-727
-2% -$86.2K 0.05% 364
2018
Q1
$4.26M Sell
36,136
-1,017
-3% -$122K 0.05% 400
2017
Q4
$4.38M Buy
+37,153
New +$4.18M 0.05% 407

Other funds holding EFX

MetLife Investment Management's EFX Position: Q1 2026 in Review

MetLife Investment Management reduced its Equifax (EFX) stake by 4.1% in Q1 2026, selling an estimated $246K and leaving 29,114 shares worth $5.24M. The position accounts for 0.03% of the portfolio, ranked #601.

MetLife Investment Management first reported a position in EFX in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.78M in Q3 2024. 871 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • MetLife Investment Management held 29,114 shares of Equifax worth $5.24M as of Q1 2026.
  • MetLife Investment Management sold 1,239 Equifax shares in Q1 2026, an estimated $246K.
  • Equifax made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #601 holding.
  • MetLife Investment Management first reported a position in Equifax in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Equifax position peaked at $9.78M in Q3 2024.
  • 871 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.